COVID-19 Vaccines

Part 1: About COVID-19 Vaccines
With Angela Rasmussen, PhD
How confident are you in your knowledge of how the COVID-19 vaccines work? A noted virologist with the Center for Global Health Science and Security at Georgetown University explains the SARS-CoV-2 vaccines and details how the vaccine development process unfolded.

Part 2: About COVID-19 Variants
With Angela Rasmussen, PhD
Uncertainty surrounds the impact of COVID-19 variants on the global pandemic. Dr. Rasmussen, of the Center for Global Health Science and Security at Georgetown University, returns to discuss the state of the science on variants circulating in the U.S.

Vaccine Appropriateness in Vulnerable Populations
With Kate Henderson, DNP, MSN, MPH, RN
Questions swirl around whether patients with immunocompromised conditions, pregnant or nursing women, and others with medical vulnerabilities should seek vaccination. Dr. Henderson, faculty at Marymount University with expertise in population health, addresses the medical consensus on vaccination of vulnerable populations.

Perspective: The Data on Vaccine Side Effects
With Libbe Englander, PhD
Patients and nurses alike cite concern about side effects as a chief reason they resist COVID-19 vaccination. A specialist in healthcare analytics crunched the numbers and gives an evidence-based perspective on the incidence of vaccine adverse events.
Download the Data Summary

About COVID-19 Long Haul Syndrome
With Eric Topol, MD, PhD
One-third of COVID-19 survivors continue to experience life-altering symptoms months after recovery. Dr. Topol of Scripps Research explains what is known about COVID-19 Long Haul Syndrome and what might come next for those with lasting symptoms.

The Promise of Monoclonal Antibody Treatment
With Ernesto Oviedo-Orta, MD, PhD, MBA
Early intervention with monoclonal antibody treatment has been shown to reduce the risk of severe illness in patients hospitalized with COVID-19. Dr. Oviedo-Orta, infectious disease lead and senior director of medical affairs at Regeneron, which manufactures an antibody cocktail for SARS-CoV-2, explains the treatment for high-risk patients.

COVID-19 Vaccination: Ethical Considerations
With Carol Taylor, PhD, RN, FAAN
Among the many ethical dilemmas faced by nurses during the COVID-19 pandemic, a question lingers: Are nurses ethically obliged to be vaccinated against the virus? Hear an answer from a senior clinical scholar at Georgetown University. Dr. Taylor was a founding member of the university’s Pellegrino Center for Clinical Bioethics.

Vaccine Uptake in the African-American Community
With Katie Boston-Leary, PhD, RN
Media reports have focused on vaccine hesitancy among African-Americans, but is it reluctance or other barriers that deter this community from vaccine uptake? Join Dr. Boston-Leary, director of nursing programs at the American Nurses Association, for a discussion of the issues.

Vaccine Uptake in the Hispanic Community
With Adriana Perez, PhD, RN
Learn about barriers to vaccination facing the Hispanic community and ways to build confidence in COVID-19 vaccines among Hispanic Americans and immigrants with Dr. Perez, an assistant professor at the University of Pennsylvania School of Nursing and former president of the National Hispanic Nurses Association, Phoenix chapter.

Vaccine Uptake in Rural Communities
With Robyn Seamon, MA, RN
Data shows fewer rural residents than urban residents plan to receive a COVID-19 vaccine. Gain understanding of the sources of vaccine uncertainty and barriers to vaccination in Appalachia and other rural communities in this conversation with a homegrown nurse who passionately works to end healthcare disparities in rural regions.